APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hepatitis Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Hepatitis Vaccine Industry Growth and Trends Forecast to 2032

2 January 2026100 pages

Choose your research edition.

Industry ResearchHepatitis Vaccine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Hepatitis Vaccine Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Hepatitis Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hepatitis Vaccine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Hepatitis Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Hepatitis Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Hepatitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Hepatitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hepatitis Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hepatitis Vaccine include Bio Kangtai, ChangSheng, Dynavax, Hissen, IMBCA, KM Biologics, LG Life Sciences, NCPC and Serum Institute, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Hepatitis Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hepatitis Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hepatitis Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hepatitis Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hepatitis Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hepatitis Vaccine Market by Company

Bio Kangtai

ChangSheng

Dynavax

Hissen

IMBCA

KM Biologics

LG Life Sciences

NCPC

Serum Institute

Sinovac

Zhejiang Pukang

GSK

Merck

Sanofi

Hepatitis Vaccine Segment by Type

Hepatitis A Vaccines

Hepatitis B Vaccines

Hepatitis Vaccine Segment by Application

Children

Adult

Hepatitis Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hepatitis Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hepatitis Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hepatitis Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Hepatitis A Vaccines Table 2. Major Company of Hepatitis B Vaccines Table 3. Global Hepatitis Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Hepatitis Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Hepatitis Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Hepatitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Hepatitis Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Hepatitis Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Hepatitis Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Hepatitis Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Hepatitis Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Hepatitis Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Hepatitis Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Hepatitis Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Hepatitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Hepatitis Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Hepatitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Hepatitis Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Hepatitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Hepatitis Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Hepatitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Hepatitis Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Hepatitis Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Hepatitis Vaccine Industry Trends Table 25. Hepatitis Vaccine Industry Drivers Table 26. Hepatitis Vaccine Industry Opportunities and Challenges Table 27. Hepatitis Vaccine Industry Restraints Table 28. Global Hepatitis Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Hepatitis Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Hepatitis Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Hepatitis Vaccine Sales Share by Company (2021-2026) Table 32. Global Hepatitis Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Hepatitis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Hepatitis Vaccine Major Company Production Sites and Headquarters Table 35. Global Hepatitis Vaccine Company, Product Type & Application Table 36. Global Hepatitis Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Hepatitis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Hepatitis Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Hepatitis Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Hepatitis Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Hepatitis Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Hepatitis Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Hepatitis Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Hepatitis Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Hepatitis Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Hepatitis Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Hepatitis Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Hepatitis Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Hepatitis Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Hepatitis Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Hepatitis Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Hepatitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Hepatitis Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Hepatitis Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Hepatitis Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Hepatitis Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Hepatitis Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Hepatitis Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Hepatitis Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Hepatitis Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Hepatitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Hepatitis Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Hepatitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Hepatitis Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Hepatitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Hepatitis Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Hepatitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Hepatitis Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Hepatitis Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. Bio Kangtai Company Information Table 72. Bio Kangtai Business Overview Table 73. Bio Kangtai Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Bio Kangtai Hepatitis Vaccine Product Portfolio Table 75. Bio Kangtai Recent Development Table 76. ChangSheng Company Information Table 77. ChangSheng Business Overview Table 78. ChangSheng Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. ChangSheng Hepatitis Vaccine Product Portfolio Table 80. ChangSheng Recent Development Table 81. Dynavax Company Information Table 82. Dynavax Business Overview Table 83. Dynavax Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Dynavax Hepatitis Vaccine Product Portfolio Table 85. Dynavax Recent Development Table 86. Hissen Company Information Table 87. Hissen Business Overview Table 88. Hissen Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Hissen Hepatitis Vaccine Product Portfolio Table 90. Hissen Recent Development Table 91. IMBCA Company Information Table 92. IMBCA Business Overview Table 93. IMBCA Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. IMBCA Hepatitis Vaccine Product Portfolio Table 95. IMBCA Recent Development Table 96. KM Biologics Company Information Table 97. KM Biologics Business Overview Table 98. KM Biologics Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. KM Biologics Hepatitis Vaccine Product Portfolio Table 100. KM Biologics Recent Development Table 101. LG Life Sciences Company Information Table 102. LG Life Sciences Business Overview Table 103. LG Life Sciences Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. LG Life Sciences Hepatitis Vaccine Product Portfolio Table 105. LG Life Sciences Recent Development Table 106. NCPC Company Information Table 107. NCPC Business Overview Table 108. NCPC Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. NCPC Hepatitis Vaccine Product Portfolio Table 110. NCPC Recent Development Table 111. Serum Institute Company Information Table 112. Serum Institute Business Overview Table 113. Serum Institute Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Serum Institute Hepatitis Vaccine Product Portfolio Table 115. Serum Institute Recent Development Table 116. Sinovac Company Information Table 117. Sinovac Business Overview Table 118. Sinovac Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Sinovac Hepatitis Vaccine Product Portfolio Table 120. Sinovac Recent Development Table 121. Zhejiang Pukang Company Information Table 122. Zhejiang Pukang Business Overview Table 123. Zhejiang Pukang Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Zhejiang Pukang Hepatitis Vaccine Product Portfolio Table 125. Zhejiang Pukang Recent Development Table 126. GSK Company Information Table 127. GSK Business Overview Table 128. GSK Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. GSK Hepatitis Vaccine Product Portfolio Table 130. GSK Recent Development Table 131. Merck Company Information Table 132. Merck Business Overview Table 133. Merck Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Merck Hepatitis Vaccine Product Portfolio Table 135. Merck Recent Development Table 136. Sanofi Company Information Table 137. Sanofi Business Overview Table 138. Sanofi Hepatitis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Sanofi Hepatitis Vaccine Product Portfolio Table 140. Sanofi Recent Development Table 141. North America Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. North America Hepatitis Vaccine Sales by Country (2021-2026) & (K Units) Table 143. North America Hepatitis Vaccine Sales Market Share by Country (2021-2026) Table 144. North America Hepatitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 145. North America Hepatitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 146. North America Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Hepatitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Hepatitis Vaccine Market Share by Country (2021-2026) Table 149. North America Hepatitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Hepatitis Vaccine Market Share Forecast by Country (2027-2032) Table 151. Europe Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Europe Hepatitis Vaccine Sales by Country (2021-2026) & (K Units) Table 153. Europe Hepatitis Vaccine Sales Market Share by Country (2021-2026) Table 154. Europe Hepatitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 155. Europe Hepatitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Hepatitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Hepatitis Vaccine Market Share by Country (2021-2026) Table 159. Europe Hepatitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Hepatitis Vaccine Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Hepatitis Vaccine Sales by Country (2021-2026) & (K Units) Table 163. Asia-Pacific Hepatitis Vaccine Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Hepatitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 165. Asia-Pacific Hepatitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Hepatitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Hepatitis Vaccine Market Share by Country (2021-2026) Table 169. Asia-Pacific Hepatitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Hepatitis Vaccine Market Share Forecast by Country (2027-2032) Table 171. Latin America Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Latin America Hepatitis Vaccine Sales by Country (2021-2026) & (K Units) Table 173. Latin America Hepatitis Vaccine Sales Market Share by Country (2021-2026) Table 174. Latin America Hepatitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 175. Latin America Hepatitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Hepatitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Hepatitis Vaccine Market Share by Country (2021-2026) Table 179. Latin America Hepatitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Hepatitis Vaccine Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Hepatitis Vaccine Sales by Country (2021-2026) & (K Units) Table 183. Middle East and Africa Hepatitis Vaccine Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Hepatitis Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 185. Middle East and Africa Hepatitis Vaccine Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Hepatitis Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Hepatitis Vaccine Market Share by Country (2021-2026) Table 189. Middle East and Africa Hepatitis Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Hepatitis Vaccine Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Hepatitis Vaccine Distributors List Table 194. Hepatitis Vaccine Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Hepatitis Vaccine Image Figure 2. Global Hepatitis Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hepatitis Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Hepatitis Vaccine Sales (2021-2032) & (K Units) Figure 5. Hepatitis A Vaccines Image Figure 6. Global Hepatitis A Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 7. Hepatitis B Vaccines Image Figure 8. Global Hepatitis B Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Hepatitis Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Hepatitis Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Hepatitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Hepatitis Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Hepatitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Hepatitis Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Hepatitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Hepatitis Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Hepatitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Hepatitis Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Hepatitis Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Hepatitis Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Hepatitis Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Children Image Figure 24. Global Children Sales YoY Growth (2021-2032) & (K Units) Figure 25. Adult Image Figure 26. Global Adult Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Hepatitis Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Hepatitis Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Hepatitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Hepatitis Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Hepatitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Hepatitis Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Hepatitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Hepatitis Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Hepatitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Hepatitis Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Hepatitis Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Hepatitis Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Hepatitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Hepatitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Hepatitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Hepatitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Hepatitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Hepatitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Hepatitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Hepatitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Hepatitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Hepatitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Hepatitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Hepatitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Hepatitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Hepatitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Hepatitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Hepatitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Hepatitis Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Hepatitis Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Hepatitis Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Hepatitis Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Hepatitis Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Hepatitis Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Hepatitis A Vaccines
  • Hepatitis B Vaccines
Applications
  • Children
  • Adult
Companies covered
  • Bio Kangtai
  • ChangSheng
  • Dynavax
  • Hissen
  • IMBCA
  • KM Biologics
  • LG Life Sciences
  • NCPC
  • Serum Institute
  • Sinovac
  • Zhejiang Pukang
  • GSK
  • Merck
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hepatitis Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hepatitis Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hepatitis Vaccine Market by Type
  6. 1.3.1 Hepatitis A Vaccines
  7. 1.3.2 Hepatitis B Vaccines
  8. 1.4 Global Hepatitis Vaccine Market Size by Type
  9. 1.4.1 Global Hepatitis Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Hepatitis Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Hepatitis Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Hepatitis Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Hepatitis Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Hepatitis Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Hepatitis Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Hepatitis Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hepatitis Vaccine Industry Trends
  2. 2.2 Hepatitis Vaccine Industry Drivers
  3. 2.3 Hepatitis Vaccine Industry Opportunities and Challenges
  4. 2.4 Hepatitis Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hepatitis Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Hepatitis Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Hepatitis Vaccine Price (2021-2026)
  4. 3.4 Global Hepatitis Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hepatitis Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Hepatitis Vaccine Company, Product Type & Application
  7. 3.7 Global Hepatitis Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hepatitis Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hepatitis Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hepatitis Vaccine Tier 1, Tier 2, and Tier 3
4 Hepatitis Vaccine Regional Status and Outlook
  1. 4.1 Global Hepatitis Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hepatitis Vaccine Historic Market Size by Region
  3. 4.2.1 Global Hepatitis Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hepatitis Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hepatitis Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hepatitis Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Hepatitis Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hepatitis Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hepatitis Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hepatitis Vaccine by Application
  1. 5.1 Hepatitis Vaccine Market by Application
  2. 5.1.1 Children
  3. 5.1.2 Adult
  4. 5.2 Global Hepatitis Vaccine Market Size by Application
  5. 5.2.1 Global Hepatitis Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Hepatitis Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Hepatitis Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Hepatitis Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Hepatitis Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Hepatitis Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Hepatitis Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Hepatitis Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bio Kangtai
  2. 6.1.1 Bio Kangtai Company Information
  3. 6.1.2 Bio Kangtai Business Overview
  4. 6.1.3 Bio Kangtai Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bio Kangtai Hepatitis Vaccine Product Portfolio
  6. 6.1.5 Bio Kangtai Recent Developments
  7. 6.2 ChangSheng
  8. 6.2.1 ChangSheng Company Information
  9. 6.2.2 ChangSheng Business Overview
  10. 6.2.3 ChangSheng Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 ChangSheng Hepatitis Vaccine Product Portfolio
  12. 6.2.5 ChangSheng Recent Developments
  13. 6.3 Dynavax
  14. 6.3.1 Dynavax Company Information
  15. 6.3.2 Dynavax Business Overview
  16. 6.3.3 Dynavax Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Dynavax Hepatitis Vaccine Product Portfolio
  18. 6.3.5 Dynavax Recent Developments
  19. 6.4 Hissen
  20. 6.4.1 Hissen Company Information
  21. 6.4.2 Hissen Business Overview
  22. 6.4.3 Hissen Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hissen Hepatitis Vaccine Product Portfolio
  24. 6.4.5 Hissen Recent Developments
  25. 6.5 IMBCA
  26. 6.5.1 IMBCA Company Information
  27. 6.5.2 IMBCA Business Overview
  28. 6.5.3 IMBCA Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 IMBCA Hepatitis Vaccine Product Portfolio
  30. 6.5.5 IMBCA Recent Developments
  31. 6.6 KM Biologics
  32. 6.6.1 KM Biologics Company Information
  33. 6.6.2 KM Biologics Business Overview
  34. 6.6.3 KM Biologics Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 KM Biologics Hepatitis Vaccine Product Portfolio
  36. 6.6.5 KM Biologics Recent Developments
  37. 6.7 LG Life Sciences
  38. 6.7.1 LG Life Sciences Company Information
  39. 6.7.2 LG Life Sciences Business Overview
  40. 6.7.3 LG Life Sciences Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 LG Life Sciences Hepatitis Vaccine Product Portfolio
  42. 6.7.5 LG Life Sciences Recent Developments
  43. 6.8 NCPC
  44. 6.8.1 NCPC Company Information
  45. 6.8.2 NCPC Business Overview
  46. 6.8.3 NCPC Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 NCPC Hepatitis Vaccine Product Portfolio
  48. 6.8.5 NCPC Recent Developments
  49. 6.9 Serum Institute
  50. 6.9.1 Serum Institute Company Information
  51. 6.9.2 Serum Institute Business Overview
  52. 6.9.3 Serum Institute Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Serum Institute Hepatitis Vaccine Product Portfolio
  54. 6.9.5 Serum Institute Recent Developments
  55. 6.10 Sinovac
  56. 6.10.1 Sinovac Company Information
  57. 6.10.2 Sinovac Business Overview
  58. 6.10.3 Sinovac Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sinovac Hepatitis Vaccine Product Portfolio
  60. 6.10.5 Sinovac Recent Developments
  61. 6.11 Zhejiang Pukang
  62. 6.11.1 Zhejiang Pukang Company Information
  63. 6.11.2 Zhejiang Pukang Business Overview
  64. 6.11.3 Zhejiang Pukang Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Zhejiang Pukang Hepatitis Vaccine Product Portfolio
  66. 6.11.5 Zhejiang Pukang Recent Developments
  67. 6.12 GSK
  68. 6.12.1 GSK Company Information
  69. 6.12.2 GSK Business Overview
  70. 6.12.3 GSK Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 GSK Hepatitis Vaccine Product Portfolio
  72. 6.12.5 GSK Recent Developments
  73. 6.13 Merck
  74. 6.13.1 Merck Company Information
  75. 6.13.2 Merck Business Overview
  76. 6.13.3 Merck Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Merck Hepatitis Vaccine Product Portfolio
  78. 6.13.5 Merck Recent Developments
  79. 6.14 Sanofi
  80. 6.14.1 Sanofi Company Information
  81. 6.14.2 Sanofi Business Overview
  82. 6.14.3 Sanofi Hepatitis Vaccine Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Sanofi Hepatitis Vaccine Product Portfolio
  84. 6.14.5 Sanofi Recent Developments
7 North America by Country
  1. 7.1 North America Hepatitis Vaccine Sales by Country
  2. 7.1.1 North America Hepatitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hepatitis Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Hepatitis Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hepatitis Vaccine Market Size by Country
  6. 7.2.1 North America Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hepatitis Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Hepatitis Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hepatitis Vaccine Sales by Country
  2. 8.1.1 Europe Hepatitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hepatitis Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Hepatitis Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hepatitis Vaccine Market Size by Country
  6. 8.2.1 Europe Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hepatitis Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hepatitis Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hepatitis Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Hepatitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hepatitis Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hepatitis Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hepatitis Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hepatitis Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hepatitis Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hepatitis Vaccine Sales by Country
  2. 10.1.1 South America Hepatitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hepatitis Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Hepatitis Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hepatitis Vaccine Market Size by Country
  6. 10.2.1 South America Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hepatitis Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Hepatitis Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hepatitis Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Hepatitis Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hepatitis Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hepatitis Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hepatitis Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Hepatitis Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hepatitis Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hepatitis Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hepatitis Vaccine Value Chain Analysis
  2. 12.1.1 Hepatitis Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hepatitis Vaccine Production Mode & Process
  7. 12.2 Hepatitis Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hepatitis Vaccine Distributors
  10. 12.2.3 Hepatitis Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst